BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22612293)

  • 1. Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer.
    Kucukgergin C; Isman FK; Cakmakoglu B; Sanli O; Seckin S
    DNA Cell Biol; 2012 Aug; 31(8):1418-24. PubMed ID: 22612293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
    Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
    Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
    Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
    Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
    Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
    Zambra FM; Biolchi V; Brum IS; Chies JA
    Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of monocyte chemotactic protein-1 and CC chemokine receptor 2 gene variants with chronic obstructive pulmonary disease.
    Bai J; Song H; Cai C; Zhang M; Xu S; Tan J
    DNA Cell Biol; 2012 Jun; 31(6):1058-63. PubMed ID: 22276574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCP-1 and CCR2 gene variants in oral squamous cell carcinoma.
    Bektas-Kayhan K; Unur M; Boy-Metin Z; Cakmakoglu B
    Oral Dis; 2012 Jan; 18(1):55-9. PubMed ID: 21883707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
    Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
    Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR2-64I is a risk factor for development of bladder cancer.
    Narter KF; Agachan B; Sozen S; Cincin ZB; Isbir T
    Genet Mol Res; 2010 Apr; 9(2):685-92. PubMed ID: 20449800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine receptor 2-V64I and chemokine receptor 5-Delta32 polymorphisms and clinical risk factors of delayed graft function and acute rejection in kidney transplantation.
    Azmandian J; Mandegary A; Saber A; Torshabi M; Etminan A; Ebadzadeh MR; Fazeli F; Soleymani S; Taghipour A; Karimi MA
    Iran J Kidney Dis; 2012 Jan; 6(1):56-62. PubMed ID: 22218121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CCL2 and CCR2 gene variants with endometrial cancer in Turkish women.
    Attar R; Agachan B; Kuran SB; Cacina C; Sozen S; Yurdum LM; Attar E; Isbir T
    In Vivo; 2010; 24(2):243-8. PubMed ID: 20364004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of cancer: a meta-analysis.
    Cho YA; Kim J
    Cytokine; 2013 Oct; 64(1):213-20. PubMed ID: 23876399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MCP-1, CCR2 and CCR5 polymorphisms in Tunisian patients with atopic asthma.
    Dhaouadi T; Sfar I; Aounallah-Skhiri H; Jendoubi-Ayed S; Bouacha H; Ben Abdallah T; Gorgi Y
    Iran J Allergy Asthma Immunol; 2013 Mar; 12(1):29-36. PubMed ID: 23454776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of chemokine and chemokine receptor genes in Type 1 diabetes mellitus and its complications.
    Yang B; Houlberg K; Millward A; Demaine A
    Cytokine; 2004 May; 26(3):114-21. PubMed ID: 15135805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of CCR5-Δ32 and CCR2-V64I polymorphisms in a mixed population from northeastern Brazil.
    Ferreira-Fernandes H; Santos AC; Motta FJ; Canalle R; Yoshioka FK; Burbano RR; Rey JA; da Silva BB; Pinto GR
    Genet Mol Res; 2015 Oct; 14(4):11710-8. PubMed ID: 26436495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection.
    Li H; Liu TJ; Hong ZH
    Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of chemokine receptor CCR2 and CCR5 gene polymorphism on allograft outcome in North Indian renal transplant recipients.
    Singh R; Kapoor R; Srivastava A; Mittal RD
    Scand J Immunol; 2009 Jan; 69(1):51-6. PubMed ID: 19037908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCP-1 and CCR2 gene variants and the risk for osteoporosis and osteopenia.
    Eraltan H; Cacina C; Kahraman OT; Kurt O; Aydogan HY; Uyar M; Can A; Cakmakoğlu B
    Genet Test Mol Biomarkers; 2012 Apr; 16(4):229-33. PubMed ID: 22081934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR2-64I gene polymorphism increase susceptibility to oral cancer.
    Chen MK; Yeh KT; Chiou HL; Lin CW; Chung TT; Yang SF
    Oral Oncol; 2011 Jul; 47(7):577-82. PubMed ID: 21570337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.